BioCancell Reports Positive Results On Pancreatic Cancer Treatment

Israeli company BioCancell Therapeutics Ltd., has announced positive results in a Phase IIb clinical trial of its BC-819 treatment for pancreatic cancer. The study showed that the drug is safe for all patients and that increasing the dosage of the drug does not cause deterioration in the patients’ condition.